Method for extracting DNA (deoxyribonucleic acid) from exhaled air condensate
By using the Genomeplex Single Cell Whole Genome Amplication Kit, and employing steps such as centrifugation, incubation, heat treatment, and PCR amplification, the problem of low DNA concentration in exhaled breath condensate was solved, resulting in a significant increase in DNA concentration that meets the requirements of whole exome sequencing and PCR, thus promoting the screening and detection of respiratory diseases.
Patent Information
- Application Number
- CN202410916753.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-09
- Publication Date
- 2024-11-12
AI Technical Summary
In existing technologies, the concentration of DNA in exhaled breath condensate is extremely low, making it difficult to extract effectively. This results in significant challenges in further detecting DNA methylation and gene mutations, and fails to provide useful information for the diagnosis and monitoring of lung diseases.
The Genomeplex Single Cell Whole Genome Amplication Kit was used to increase the concentration of DNA in exhaled breath condensate through a series of steps including centrifugation, incubation, heat treatment, and PCR amplification. The specific steps included centrifugation followed by discarding the supernatant, mixing, incubation, adding buffer and enzyme preparations, heat treatment, and PCR amplification.
It significantly increased the concentration of DNA in exhaled breath condensate, enabling it to meet the requirements of whole-exome sequencing and PCR, thus facilitating the screening and detection of respiratory diseases.
Smart Images

Figure CN118932017A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of pharmaceutical technology, and in particular to a method for extracting DNA from exhaled breath condensate. Background Art
[0002] Exhaled breath condensate (EBC), composed of respiratory lining fluid and volatile compounds, is a new and important source of biomarkers for respiratory diseases and has high clinical research value. In recent years, the study of exhaled breath condensate has gradually increased because this easy-to-sample fluid has significantly different characteristics between patients and healthy people in lung diseases. These tests provide evidence for the acid-base status of the airways and lungs and the degree and type of inflammation in acute and chronic asthma, lung cancer, chronic obstructive pulmonary disease, and adult respiratory distress syndrome. However, exhaled breath condensate is characterized by different dilution levels and cannot accurately assess the concentration of individual solutes in the respiratory lining fluid. It can only provide useful information when the concentrations between healthy people and patients are very different. Since exhaled breath condensate testing can be used to measure therapeutic targets and, after further technical work is completed, it can also be used to diagnose and monitor treatment in individual patients, it may become one of the hot spots for future clinical research.
[0003] Currently, the pH of exhaled breath condensate has been proposed as a non-invasive marker for lung disease and respiratory inflammation. In addition, exhaled breath condensate contains cell-free DNA, which can be used to detect lung cancer gene mutations and assess the severity of diseases such as asthma. However, previous literature reports that the concentration of DNA extracted from exhaled breath condensate is extremely low, which makes it difficult to further detect DNA methylation and gene mutations. Therefore, improving the extraction method of DNA from exhaled breath condensate and improving the DNA extraction product can bring new breakthroughs to exhaled breath condensate-related research and provide new ideas for the prevention, diagnosis and treatment of respiratory diseases. Summary of the invention
[0004] The object of the present invention is to provide a method for extracting DNA from exhaled breath condensate.
[0005] The present invention solves the technical problem by adopting the following technical solutions:
[0006] In a first aspect, the present invention provides a method for extracting DNA from exhaled breath condensate, comprising the following steps:
[0007] S1. Centrifuge the exhaled breath condensate and discard the supernatant to obtain a suspension;
[0008] S2, mixing the suspension and the incubation working solution to obtain a mixed solution A;
[0009] S3, incubate the mixed solution A and cool it to room temperature, then add 1× single cell library preparation buffer, 1× Single cell library preparation buffer and Library stabilization solution, mix well, and obtain mixed solution B;
[0010] S4, after heat treatment of the mixed solution B, cool it to room temperature, add Library preparation Enzyme and mix well to obtain a mixed solution C;
[0011] S5, subjecting the mixed solution C to programmed temperature treatment and then cooling it, adding 10×Amplication master mix, water and WGA DNA Polymerase, and mixing well to obtain mixed solution D;
[0012] S6. Perform PCR amplification on the mixed solution D and measure the DNA concentration.
[0013] In an embodiment of the present invention, the incubation working solution includes proteinase K and 10× single cell lysis solution.
[0014] In an embodiment of the present invention, the volume ratio of the suspension to the incubation working solution is 9:(0.1-2); the volume ratio of the proteinase K to the 10× single cell lysis solution is 1:(10-25).
[0015] In an embodiment of the present invention, the volume ratio of the suspension to the incubation working solution is 9:(0.8-1.2); the volume ratio of the proteinase K to the 10× single cell lysis solution is 1:(15-18).
[0016] In an embodiment of the present invention, the volume ratio of the suspension, 1× single cell library preparation buffer, 1× Single cell library preparation Buffer and Library stabilization Solution is 9: (1-3): (0.5-1.5): (0.5-1.5);
[0017] The volume ratio of the suspension to the Library preparation Enzyme is 9:(0.5-1.5);
[0018] The volume ratio of the suspension, 10×Amplication master mix and WGA DNA Polymerase is 9:(2-7):(1-5).
[0019] In an embodiment of the present invention, the volume ratio of the suspension, 1× single cell library preparation buffer, 1× Single cell library preparation Buffer and Library stabilization Solution is 9: (1.8-2.2): (0.8-1.2): (0.8-1.2);
[0020] The volume ratio of the suspension to the Library preparation Enzyme is 9:(0.8-1.2);
[0021] The volume ratio of the suspension, 10×Amplication master mix and WGA DNA Polymerase is 9:(3.5-4.5):(2-3).
[0022] In the embodiment of the present invention, the incubation process in step S3 is as follows: incubating the mixed solution A at 40-60° C. for 0.5-1.5 h, and then heating to 95-100° C. for 2-8 min;
[0023] The heat treatment process in step S4 is as follows: keeping the mixed solution B at 80-110° C. for 30 seconds to 10 minutes;
[0024] The programmed temperature rise process in step S5 is as follows: keeping the mixed solution C at 10-25°C for 10-30 min, heating it to 20-30°C and keeping it for 10-30 min, heating it to 30-45°C and keeping it for 10-30 min, heating it to 65-80°C and keeping it for 10-30 min, cooling it down to 0-10°C and cooling it down;
[0025] The PCR amplification in step S6 is as follows: ①, maintaining at 94-100° C. for 1-10 min, ②, continuing to maintain at 92-94° C. for 15-60 s, ③, cooling to 50-70° C. and maintaining for 1-10 min; ④, cycling steps ② and ③ 20-30 times.
[0026] In the embodiment of the present invention, the incubation process in step S3 is as follows: incubating the mixed solution A at 45-55° C. for 0.8-1.2 h, and then heating to 98-100° C. for 2-6 min;
[0027] The heat treatment process in step S4 is as follows: maintaining the mixed solution B at 92-98° C. for 1-4 minutes;
[0028] The programmed temperature rising process in step S5 is as follows: keeping the mixed solution C at 14-18°C for 18-22 minutes, heating it to 22-26°C and keeping it for 18-22 minutes, heating it to 35-40°C and keeping it for 18-22 minutes, heating it to 72-78°C and keeping it for 18-22 minutes, cooling it to 2-6°C and cooling it;
[0029] The PCR amplification in step S6 is as follows: ①, maintaining at 95° C. for 2 to 4 minutes, ②, continuing to maintain at 94° C. for 25 to 35 seconds, ③, cooling to 65° C. and maintaining for 4 to 6 minutes; ④, cycling steps ② and ③ for 20 to 30 times.
[0030] The present invention includes the following beneficial effects: the method of the present invention utilizes the Genomeplex Single Cell Whole Genome Amplication Kit to amplify all genes in the exhaled breath condensate. The method amplifies the DNA in the exhaled breath condensate to increase its concentration, which can meet the requirements of whole exome sequencing and PCR, and can facilitate the screening and detection of various respiratory diseases. BRIEF DESCRIPTION OF THE DRAWINGS
[0031] Figure 1 This is the distribution diagram of sequencing base quality values on clean reads.
[0032] Figure 2 This is the cumulative sequencing depth distribution diagram.
[0033] Figure 3 The insert fragment length distribution of paired sequencing reads.
[0034] Figure 4 This is the length distribution diagram of InDels in the coding region.
[0035] Figure 5 Interaction diagram of gene mutations in exhaled breath condensate samples.
[0036] Unless stated to the contrary, the terms used in the specification and claims have the following meanings.
[0037] As used herein, the term "prevention" refers to preventing the occurrence of a disease and / or preventing the recurrence of a disease. DETAILED DESCRIPTION
[0038] The present invention specification describes the specific implementation scheme in detail. Those skilled in the art should recognize that the following implementation scheme is exemplary and cannot be understood as limiting the present invention. For those skilled in the art, without departing from the principle of the present invention, by making several improvements and modifications to the present invention, the technical solutions obtained by these improvements and modifications also fall within the protection scope of the claims of the present invention. The following examples specifically illustrate the beneficial effects of the present invention.
[0039] Buy Genomeplex Single Cell Whole Genome Amplication Kit;
[0040] Prepare the incubation working solution: mix 2ul proteinase K and 32uL 10× single cell lysis buffer (all the above reagents are from the kit);
[0041] Single cell library preparation buffer (Add 2ul 1×Single cell library preparation buffer to every 9ul of precipitation) (from the kit)
[0042] Library stabilization solution, from the kit
[0043] Enzyme preparation (Library preparation Enzyme), from the kit
[0044] Amplication master mix, from the kit
[0045] DNA polymerase (WGA DNA Polymerase), from the kit
[0046] Through the patent of Professor Wang Guangfa's team from the Department of Respiratory and Critical Care Medicine of Peking University First Hospital - an exhaled breath condensate collector (application number 201921297152.7), exhaled breath condensate is collected, and the mouth is rinsed with saline before collection to eliminate interference factors.
[0047] Example 1
[0048] A method for extracting DNA from exhaled breath condensate comprises the following steps:
[0049] Step 1: Thaw 1 ml of exhaled breath condensate sample at room temperature, centrifuge (12000 r / min, 15 min) and discard the supernatant;
[0050] Step 2: Measure the suspension volume to 18ul, add 2ul of incubation working solution (add 1ul of working solution for every 9ul of precipitation, if the precipitation volume is less than 9ul, add water to make up to 9ul) and mix well to obtain mixed solution A;
[0051] Step 3: Incubate the mixture A at 50°C for 1 h, heat to 99°C for 4 min, and then cool on ice to room temperature;
[0052] Step 4: Add 4ul 1× Single cell library preparation buffer (2ul 1× Single cell library preparation buffer for every 9ul of precipitation) to the cooled mixed solution A; then add 2ul Library stabilization solution and mix well to obtain mixed solution B;
[0053] Step 5: Heat the mixed solution B at 95°C for 2 min and cool it to room temperature on ice;
[0054] Step 6. Add 2ul of Library preparation Enzyme (1ul of Library preparation Enzyme per 9ul of precipitation) to the cooled mixed solution B and mix well to obtain mixed solution C.
[0055] Step 7: Mixture C is operated according to the following steps: ①, keep at 16℃ for 20min; ②, heat to 24℃, keep for 20min; ③, heat to 37℃, keep for 20min; ④, heat to 75℃, hold for 20min; ⑤, hold at 4℃;
[0056] Step 8. Add 7.5ul 10×Amplication master mix to the cooled solution C, then add 34.5ul water, and finally add 5ul WGA DNA Polymerase, mix well, and obtain mixed solution D; the total volume is 75ul. Due to the volume change caused by the different precipitation volumes, the volume is adjusted by the volume of water;
[0057] Step 9, amplify the mixed solution D using the following procedure: ①, 95°C, keep for 3 min; ②, 94°C, keep for 30 s; ③, 65°C, keep for 5 min; ④, cycle ② and ③ 25 times;
[0058] Step 10: Measure the DNA concentration and use it for subsequent experiments such as whole exome sequencing.
[0059] Experimental Section
[0060] 1. Comparison of the extraction method using Example 1
[0061] ①. Specimen source: Specimen No. 1 EBC; Specimen No. 2 EBC; Specimen No. 3 EBC.
[0062] ②. Concentration detection method: ultra-micro spectrophotometer, detection limit: 0.5ng / μl
[0063] Experimental results: The results of the conventional extraction method and the extraction method of Example 1 are shown in Table 1.
[0064] DNA concentration Specimen No. 1 Sample No. 2 Sample No. 3 Before extraction Concentration below the detection limit Concentration below the detection limit Concentration below the detection limit After extraction 44.20ng / μl 43.90ng / μl 33.92ng / μl
[0065] Table 1
[0066] Therefore, the DNA concentration obtained by the extraction method of Example 1 can meet the requirements of whole exome sequencing and PCR, which solves the difficulties of the prior art and can facilitate the screening and detection of various respiratory diseases.
[0067] 2. Comparison of conventional extraction method and the extraction method of Example 1
[0068] ①. Conventional extraction method: DNA extraction from EBC samples using QIAamp DNA Mini Kit
[0069] ②. Specimen source: Specimen No. 1 EBC; Specimen No. 2 EBC; Specimen No. 3 EBC.
[0070] ③. Concentration detection method: ultra-micro spectrophotometer, detection limit: 0.5ng / μl
[0071] ④. Experimental results: The results of the conventional extraction method and the extraction method of Example 1 are shown in Table 2
[0072] Extraction method Specimen No. 1 Sample No. 2 Sample No. 3 Conventional extraction 1.94ng / μl 2.42ng / μl 2.11ng / μl Example 1 44.20ng / μl 43.90ng / μl 33.92ng / μl
[0073] Table 2
[0074] Therefore, the DNA concentration after extraction by the extraction method of Example 1 is about 20 times that of the conventional extraction method. The DNA concentration obtained by the conventional extraction method cannot meet the requirements of whole exon sequencing and PCR, but the DNA concentration obtained by the extraction method of Example 1 can meet the requirements of whole exon sequencing and PCR, solving the problems of the prior art. The extraction method of the present invention can facilitate the screening and detection of various respiratory diseases.
[0075] 3. The DNA extracted by the extraction method of Example 1 was used for whole exome sequencing experiment
[0076] ①. Specimen source: EBC.
[0077] ②. Whole exome sequencing method: BGI testing, reference genome sequence: GRCh38
[0078] ③. Experimental results: Table 3 is a statistical table of sequencing data
[0079]
[0080] Table 3
[0081] As can be seen from Table 3, the whole exome sequencing results showed that each sample had higher Q20 and Q30, indicating that the sequencing quality was good.
[0082] Figure 1 This is the distribution diagram of sequencing base quality values on clean reads. Figure 1 is the quality value of the sequencing base: the logarithm of the base error rate P, which describes the reliability of each sequencing base. Figure 1 It can be seen that the samples extracted from the exhaled breath condensate have higher Q20 and Q30, and both are greater than 85%, indicating that the number of bases with a base quality value of 99% accounts for more than 85% of the total number of bases. This proves that the experimental data is reliable.
[0083] Figure 2 This is the cumulative sequencing depth distribution diagram. Figure 2 The X-axis represents the sequencing depth, and the Y-axis represents the proportion of target regions that reach the corresponding sequencing depth or above. This indicates that the proportion of exhaled breath condensate samples with a sequencing depth of more than 20× is 10%-20%.
[0084] Figure 3 The insert fragment length distribution of paired sequencing reads. Figure 3 The X-axis represents the insert length of paired sequencing reads, and the Y-axis represents the proportion of reads with corresponding fragment lengths. This figure shows that the proportion of fragment lengths of 0-50 and 100-300 in exhaled breath condensate is relatively high.
[0085] Figure 4 This is the length distribution diagram of InDels in the coding region. Figure 4 The X-axis represents the length of the small fragment insertion / deletion, and the Y-axis represents the number of insertion / deletions. This figure shows that the number of indel sites in the coding region of the small fragment of the exhaled breath condensate sample is relatively large.
[0086] Figure 5This is an interactive diagram of gene mutations in exhaled breath condensate samples. This indicates that a large number of mutation gene sites can be detected in the three samples extracted by this method, and further screening can provide a theoretical basis for lung cancer diagnosis.
[0087] The specification of the present invention describes the specific implementation scheme in detail. Those skilled in the art should recognize that the above implementation scheme is exemplary and cannot be understood as limiting the present invention. For those skilled in the art, without departing from the principle of the present invention, by making several improvements and modifications to the present invention, the technical solutions obtained by these improvements and modifications also fall within the scope of protection of the claims of the present invention.
Claims
1. A method for extracting DNA from exhaled breath condensate, characterized in that: The steps include: S1. Centrifuge the exhaled breath condensate and discard the supernatant to obtain a suspension; S2, mixing the suspension and the incubation working solution to obtain a mixed solution A; S3, after incubation, cool the mixed solution A to room temperature, add 1× single cell preparation buffer and stabilization treatment solution, mix well, and obtain mixed solution B; S4, heat-treating the mixed solution B, cooling it to room temperature, and then adding the enzyme preparation and mixing well to obtain a mixed solution C; S5, subjecting the mixed solution C to programmed temperature treatment and then cooling it, adding 10× main reaction mixture, water and DNA polymerase (WGA DNA Polymerase), and mixing well to obtain a mixed solution D; S6. Perform PCR amplification on the mixed solution D and measure the DNA concentration.
2. The method for extracting DNA from exhaled breath condensate according to claim 1, characterized in that: The incubation working solution includes proteinase K and 10× single cell lysis solution.
3. The method for extracting DNA from exhaled breath condensate according to claim 2, characterized in that: The volume ratio of the suspension and the incubation working solution is 9:(0.1-2); the volume ratio of the proteinase K and the 10× single cell lysis solution is 1:(10-25).
4. The method for extracting DNA from exhaled breath condensate according to claim 3, characterized in that: The volume ratio of the suspension and the incubation working solution is 9:(0.8-1.2); the volume ratio of the proteinase K and the 10× single cell lysis solution is 1:(15-18).
5. The method for extracting DNA from exhaled breath condensate according to claim 1, characterized in that: The volume ratio of the suspension, 1× single cell bank preparation buffer, 1× single cell bank preparation buffer and stabilization treatment solution is 9: (1-3): (0.5-1.5): (0.5-1.5); The volume ratio of the suspension to the enzyme preparation is 9:(0.5-1.5); The volume ratio of the suspension, 10× main reaction mixture and DNA polymerase is 9:(2-7):(1-5).
6. The method for extracting DNA from exhaled breath condensate according to claim 5, characterized in that: The volume ratio of the suspension, 1× single cell bank preparation buffer, 1× single cell bank preparation buffer and stabilization treatment solution is 9: (1.8-2.2): (0.8-1.2): (0.8-1.2); The volume ratio of the suspension to the enzyme preparation is 9:(0.8-1.2); The volume ratio of the suspension, 10× main reaction mixture and DNA polymerase is 9:(3.5-4.5):(2-3).
7. The method for extracting DNA from exhaled breath condensate according to any one of claims 1 to 4, characterized in that: The incubation process in step S3 is as follows: incubate the mixed solution A at 40-60° C. for 0.5-1.5 h, then heat it to 95-100° C. and incubate it for 2-8 min; The heat treatment process in step S4 is as follows: keeping the mixed solution B at 80-110° C. for 30 seconds to 10 minutes; The programmed temperature rise process in step S5 is as follows: keeping the mixed solution C at 10-25°C for 10-30 min, heating it to 20-30°C and keeping it for 10-30 min, heating it to 30-45°C and keeping it for 10-30 min, heating it to 65-80°C and keeping it for 10-30 min, cooling it down to 0-10°C and cooling it down; The PCR amplification in step S6 is as follows: ①, maintaining at 94-100° C. for 1-10 min, ②, continuing to maintain at 92-94° C. for 15-60 s, ③, cooling to 50-70° C. and maintaining for 1-10 min; ④, cycling steps ② and ③ 20-30 times.
8. The method for extracting DNA from exhaled breath condensate according to claim 5, characterized in that: The incubation process in step S3 is as follows: incubating the mixed solution A at 45-55° C. for 0.8-1.2 h, and then heating to 98-100° C. for 2-6 min; The heat treatment process in step S4 is as follows: maintaining the mixed solution B at 92-98° C. for 1-4 minutes; The programmed temperature rising process in step S5 is as follows: keeping the mixed solution C at 14-18°C for 18-22 minutes, heating it to 22-26°C and keeping it for 18-22 minutes, heating it to 35-40°C and keeping it for 18-22 minutes, heating it to 72-78°C and keeping it for 18-22 minutes, cooling it to 2-6°C and cooling it; The PCR amplification in step S6 is as follows: ①, maintaining at 95° C. for 2 to 4 minutes, ②, continuing to maintain at 94° C. for 25 to 35 seconds, ③, cooling to 65° C. and maintaining for 4 to 6 minutes; ④, cycling steps ② and ③ for 20 to 30 times.
